myAVOS, your Digital Aging Well Coach, your Cognitive Care Solution

Healthcare Evolution: From Clinical Trust to Self-Driven Care in a Digital Age While having a trusting relationship with a clinical professional remains central to health care, since the pandemic there are clear signs that people are more interested in their health and looking at ways to confidently manage and support themselves, without always needing to seek advice. Many apps support this wish, so now for many, consumerism is coming to health care, in a parallel way to how banking apps have changed the way people handle their finances. When they arrived people feared the loss of privacy and security. Now they are normal practice and writing a cheque is almost obsolete. Will people feel the same managing there own health data? The signs are good. People question and challenge clinicians more, using curated clinical tools and there own self collected data. Post pandemic, virtual visits, especially for routine checks are far more common. But whole scale acceptance of a consumer driven ...

  From AAIC Amsterdam: A Renewed Emphasis on Amyloid and a Fresh Look at Disease Staging in Alzheimer’s Research Interesting times at the Alzheimer’s Association International Conference (AAIC) in Amsterdam last week. Some positive findings with amyloid lowering drugs in early stages of Alzheimer’s were welcomed and seem to have led to the launch of a new 7 part staging process to measure the disease. This should amuse the researchers at New York University who published the Global Deterioration Scale back in 1988. This was used commonly at first, especially in clinical trials, but drifted out of use. But now something broadly similar is back, this time bolstered by the inclusion of biomarkers. In fact there is a stage A0, which is biomarker change, but no symptoms. Amyloid: Biomarker, Warning Sign, or Both? Delving Into the Implications for Alzheimer’s Disease Prognosis and Early Detection This starts to raise questions. It is known that amyloid accumulation affects tau proteins a...

The Economic Burden of Chronic Diseases in Aging Populations Chronic diseases are a significant and profound economic issue for individuals, the healthcare system, and society as a whole. With the aging of populations worldwide, the prevalence of chronic diseases is increasing, accounting for  90% of all medical costs in the US  and even greater worldwide. It amounts to $4.1 trillion in annual health care expenditures The presence of multiple chronic conditions in the same individual has profound implications for healthcare costs and utilization. According to the CDC, six in ten adults have a chronic disease, and four in ten adults have two or more chronic diseases in the US.  A Swiss study  found that elderly patients with multiple chronic conditions had healthcare costs 5.5 times higher than those without multiple chronic conditions. Hence, even a small reduction in the prevalence of chronic diseases can result in significant cost savings and a genuine return on in...

Harnessing the Power of myAVOS for Prevention According to the World Health Organization (WHO), stroke is the second leading cause of death worldwide, responsible for 11% of all deaths. It is also a leading cause of disability, with many stroke survivors experiencing long-term physical and cognitive impairments. When a stroke occurs, the brain is deprived of oxygen and nutrients, which can lead to damage in the affected area. This damage can affect cognitive function, including memory, attention, and decision-making. The risk of cognitive impairment after a stroke is higher for older individuals and those with a history of cognitive decline. Preventing stroke with lifestyle strategies The good news is that many strokes can be prevented through lifestyle changes and management of risk factors. This is where myAVOS, a digital health app, comes in! myAVOS is a digital health coach that targets risk factors for stroke using lifestyle strategies regarding nutrition, exercise, stress managem...